2016 Q3 Form 10-Q Financial Statement

#000156459017021779 Filed on November 06, 2017

View on sec.gov

Income Statement

Concept 2016 Q3
Revenue $8.582M
YoY Change 128.24%
Cost Of Revenue $1.882M
YoY Change 188.21%
Gross Profit $6.700M
YoY Change 115.64%
Gross Profit Margin 78.07%
Selling, General & Admin $2.780M
YoY Change -10.03%
% of Gross Profit 41.49%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $80.00K
YoY Change -52.94%
% of Gross Profit 1.19%
Operating Expenses $2.850M
YoY Change -7.77%
Operating Profit -$402.0K
YoY Change -88.41%
Interest Expense $17.00K
YoY Change -72.13%
% of Operating Profit
Other Income/Expense, Net $16.00K
YoY Change
Pretax Income -$360.0K
YoY Change -90.05%
Income Tax $11.00K
% Of Pretax Income
Net Earnings -$371.0K
YoY Change -89.8%
Net Earnings / Revenue -4.32%
Basic Earnings Per Share -$0.01
Diluted Earnings Per Share -$0.01
COMMON SHARES
Basic Shares Outstanding 28.43M
Diluted Shares Outstanding 28.43M

Balance Sheet

Concept 2016 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $3.340M
YoY Change 25.56%
Cash & Equivalents $3.341M
Short-Term Investments
Other Short-Term Assets $340.0K
YoY Change -40.35%
Inventory $890.0K
Prepaid Expenses
Receivables $1.110M
Other Receivables $0.00
Total Short-Term Assets $5.670M
YoY Change 28.28%
LONG-TERM ASSETS
Property, Plant & Equipment $160.0K
YoY Change 33.33%
Goodwill $6.158M
YoY Change
Intangibles $4.183M
YoY Change
Long-Term Investments
YoY Change
Other Assets $282.0K
YoY Change -92.5%
Total Long-Term Assets $10.78M
YoY Change -46.44%
TOTAL ASSETS
Total Short-Term Assets $5.670M
Total Long-Term Assets $10.78M
Total Assets $16.45M
YoY Change -32.99%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $8.190M
YoY Change 21.87%
Accrued Expenses
YoY Change
Deferred Revenue
YoY Change
Short-Term Debt $0.00
YoY Change
Long-Term Debt Due $1.090M
YoY Change -74.05%
Total Short-Term Liabilities $10.39M
YoY Change -15.35%
LONG-TERM LIABILITIES
Long-Term Debt $460.0K
YoY Change
Other Long-Term Liabilities $880.0K
YoY Change -64.37%
Total Long-Term Liabilities $1.340M
YoY Change -45.75%
TOTAL LIABILITIES
Total Short-Term Liabilities $10.39M
Total Long-Term Liabilities $1.340M
Total Liabilities $12.68M
YoY Change -19.22%
SHAREHOLDERS EQUITY
Retained Earnings -$280.6M
YoY Change
Common Stock $285.0K
YoY Change
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $3.769M
YoY Change
Total Liabilities & Shareholders Equity $16.45M
YoY Change -32.99%

Cashflow Statement

Concept 2016 Q3
OPERATING ACTIVITIES
Net Income -$371.0K
YoY Change -89.8%
Depreciation, Depletion And Amortization $80.00K
YoY Change -52.94%
Cash From Operating Activities $4.240M
YoY Change 821.74%
INVESTING ACTIVITIES
Capital Expenditures -$10.00K
YoY Change
Acquisitions
YoY Change
Other Investing Activities $0.00
YoY Change
Cash From Investing Activities -$10.00K
YoY Change
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -2.930M
YoY Change 474.51%
NET CHANGE
Cash From Operating Activities 4.240M
Cash From Investing Activities -10.00K
Cash From Financing Activities -2.930M
Net Change In Cash 1.300M
YoY Change -2700.0%
FREE CASH FLOW
Cash From Operating Activities $4.240M
Capital Expenditures -$10.00K
Free Cash Flow $4.250M
YoY Change 823.91%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2017Q3 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
3938000
CY2016Q4 hgbl Intangible Assets Net Excluding Goodwill One
IntangibleAssetsNetExcludingGoodwillOne
4122000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1000
us-gaap Income Taxes Paid
IncomeTaxesPaid
30000
CY2017Q3 hgbl Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
-3000
CY2016Q3 hgbl Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
1000
hgbl Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
44000
hgbl Interest And Other Income Expense Net
InterestAndOtherIncomeExpenseNet
114000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
2777000
CY2016Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
3341000
us-gaap Income Taxes Paid
IncomeTaxesPaid
19000
us-gaap Interest Paid
InterestPaid
3000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-1394000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-3347000
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
429000
us-gaap Net Cash Provided By Used In Continuing Operations
NetCashProvidedByUsedInContinuingOperations
564000
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
0
us-gaap Repayments Of Short Term Debt
RepaymentsOfShortTermDebt
2500000
hgbl Payment Of Contingent Consideration
PaymentOfContingentConsideration
897000
hgbl Payment Of Contingent Consideration
PaymentOfContingentConsideration
627000
us-gaap Interest Paid
InterestPaid
167000
CY2017Q3 hgbl Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedWeightedAverageGrantDateFairValue
0.38
us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="margin-top:6pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">The preparation of the Company&#8217;s consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and the disclosure of contingent assets and liabilities at the date of the financial statements, as well as the reported amounts of revenues and expenses during the reporting period. Management bases its estimates and judgments on historical experience and various other factors that are believed to be reasonable under the circumstances. Actual results could differ from those estimates.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">Significant estimates include the assessment of collectability of revenue recognized, and the valuation of accounts receivable, inventory, other assets, goodwill and intangible assets, liabilities, contingent consideration, deferred income tax assets and liabilities, and stock-based compensation. These estimates have the potential to significantly impact the Company&#8217;s consolidated financial statements, either because of the significance of the financial statement item to which they relate, or because they require judgment and estimation due to the uncertainty involved in measuring, at a specific point in time, events that are continuous in nature.</p></div>
us-gaap Prior Period Reclassification Adjustment Description
PriorPeriodReclassificationAdjustmentDescription
<div> <p style="margin-top:18pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-family:Times New Roman;font-size:10pt;font-style:normal;text-transform:none;font-variant: normal;">Reclassifications </p> <p style="text-align:justify;margin-top:6pt;margin-bottom:0pt;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;text-indent:4.54%;">Certain prior year balances within the condensed consolidated financial statements have been reclassified to conform to the current year presentation.</p> <p style="text-align:justify;margin-top:12pt;margin-bottom:0pt;text-indent:4.54%;font-family:Times New Roman;font-size:10pt;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The critical accounting policies used in the preparation of the Company&#8217;s audited consolidated financial statements are discussed in the Company&#8217;s Annual Report on Form 10-K for the year ended December 31, 2016. There have been no changes to these policies in the nine months ended September 30, 2017.</p></div>
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
50000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresInPeriod
149850
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
10000
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
5059350
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1912500
CY2016Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.96
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0.48
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.08
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Forfeitures In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsForfeituresInPeriodWeightedAverageExercisePrice
0.45
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
0.95
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
1.82
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod
37500
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber
0
CY2017Q3 hgbl Share Based Compensation Arrangement By Share Based Payment Award Non Option Equity Instruments Vested Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsVestedNumber
262500
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue
0.38
CY2017Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Nonvested Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue
0
CY2016Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1685000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
184000
CY2017Q3 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
1501000
us-gaap Convertible Preferred Stock Terms Of Conversion
ConvertiblePreferredStockTermsOfConversion
The Company’s Class N preferred shares, each of which is convertible to 40 common shares, have the right to receive dividends or dividend equivalents should the Company declare dividends on its common stock.
CY2017Q3 us-gaap Convertible Preferred Stock Shares Issued Upon Conversion
ConvertiblePreferredStockSharesIssuedUponConversion
40
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
10362
us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
9538
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1900000
us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
200000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
61000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
245000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
240000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
236000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
236000
CY2017Q3 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
483000
us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2016Q4 us-gaap Loans Payable
LoansPayable
1012000
CY2017Q3 us-gaap Assets Fair Value Disclosure Nonrecurring
AssetsFairValueDisclosureNonrecurring
0
CY2017Q3 us-gaap Liabilities Fair Value Disclosure Nonrecurring
LiabilitiesFairValueDisclosureNonrecurring
0
CY2017Q3 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
74500000
CY2017Q3 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
500000
hgbl Operating Loss Carryforwards Expiration
OperatingLossCarryforwardsExpiration
Substantially all of the net operating loss carry forwards and unused minimum tax credit carry forwards expire between 2024 and 2035.
us-gaap Operating Loss Carryforwards Limitations On Use
OperatingLossCarryforwardsLimitationsOnUse
The Company’s utilization of restricted net operating tax loss carry forwards against future income for tax purposes is restricted pursuant to the “change in ownership” rules in Section 382 of the Internal Revenue Code.
CY2016Q3 us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
25000
us-gaap Related Party Transaction Expenses From Transactions With Related Party
RelatedPartyTransactionExpensesFromTransactionsWithRelatedParty
150000

Files In Submission

Name View Source Status
0001564590-17-021779-index-headers.html Edgar Link pending
0001564590-17-021779-index.html Edgar Link pending
0001564590-17-021779.txt Edgar Link pending
0001564590-17-021779-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g20171106173332082128.jpg Edgar Link pending
hgbl-10q_20170930.htm Edgar Link pending
hgbl-20170930.xml Edgar Link completed
hgbl-20170930.xsd Edgar Link pending
hgbl-20170930_cal.xml Edgar Link unprocessable
hgbl-20170930_def.xml Edgar Link unprocessable
hgbl-20170930_lab.xml Edgar Link unprocessable
hgbl-20170930_pre.xml Edgar Link unprocessable
hgbl-ex311_9.htm Edgar Link pending
hgbl-ex312_8.htm Edgar Link pending
hgbl-ex321_7.htm Edgar Link pending
hgbl-ex322_6.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending